Alexander J Ambinder (Alexander Ambinder, Alex Ambinder)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Bone marrow transplantation

Cancers

American journal of hematology

Leukemia

Johns Hopkins University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johns Hopkins University Jul 01 2016

United States

Fellow :: Oncology

Publications

Ilias Sinanidis, Michael J Hochman, Hua-Ling Tsai, Michael P Randall, Brandon Bonilla, Ravi Varadhan, Alexander J Ambinder, Richard J Jones, Amy E DeZern, Theodoros Karantanos
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide. Bone marrow transplantation (2024)
Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambinder
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. Bone marrow transplantation (2024)
Ilias Sinanidis, Michael J Hochman, Hua-Ling Tsai, Michael P Randall, Brandon Bonilla, Ravi Varadhan, Alexander J Ambinder, Richard J Jones, Amy E DeZern, Theodoros Karantanos
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide. Bone marrow transplantation (2024)
Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambinder
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. Bone marrow transplantation 59 (3) (2024)
Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambinder
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. Bone marrow transplantation 59 (3) (2024)
Ilias Sinanidis, Michael J Hochman, Hua-Ling Tsai, Michael P Randall, Brandon Bonilla, Ravi Varadhan, Alexander J Ambinder, Richard J Jones, Amy E DeZern, Theodoros Karantanos
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide. Bone marrow transplantation (2024)
Ilias Sinanidis, Michael J Hochman, Hua-Ling Tsai, Michael P Randall, Brandon Bonilla, Ravi Varadhan, Alexander J Ambinder, Richard J Jones, Amy E DeZern, Theodoros Karantanos
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide. Bone marrow transplantation 59 (8) (2024)
Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambinder
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. Bone marrow transplantation (2024)
Michael J Hochman, Megan K D Othus, Robert P Hasserjian, Alexander J Ambinder, Andrew Brunner, Mary-Elizabeth M Percival, Christopher S Hourigan, Ronan Swords, Amy E DeZern, Elihu H Estey, Judith E Karp
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification. Leukemia (2023)
Yuya Nagai, Alexander J Ambinder
The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away. Cancers 15 (14) (2023)
Alexander J Ambinder, Tania Jain, Hua-Ling Tsai, Mary M Horowitz, Richard J Jones, Ravi Varadhan
HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age. Blood advances 6 (14) (2022)
Alexander J Ambinder, Bryan Hambley, Satish Shanbhag, Samuel A Merrill
Ibrutinib-associated hemophagocytic lymphohistiocytosis: A case series from Johns Hopkins. American journal of hematology 94 (11) (2019)

Alexander J Ambinder.css-eqlu8i{font-size:small;padding-left:4px;} (Alexander Ambinder, Alex Ambinder)

Publication Activity (10 Years)

Top Topics

Top Venues

Alexander J Ambinder (Alexander Ambinder, Alex Ambinder)